Concepedia

Brynjar Mauseth

BM

6

Publications

229

Citations

6

H-Index

2016

Active since

Affiliations

Oslo University Hospital(Current)

UiT The Arctic University of Norway

Lytix Biopharma (Norway)

University of Oslo

Karolinska Institutet

Brynjar Mauseth is an author at Oslo University Hospital specializing in tumor biology, medicine, and immunology.

Top concepts

Publications per year

2016–2021

6

Publications

6

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

James Spicer, Aurélien Marabelle, Jean‐François Baurain et al. · Clinical Cancer Research · 2021 · 68 citations · Full text

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model

Ketil André Camilio, Mengyu Wang, Brynjar Mauseth et al. · Breast Cancer Research · 2019 · 63 citations · Full text

Tumor lysis with LTX-401 creates anticancer immunity

Wei Xie, Laura Mondragón, Brynjar Mauseth et al. · OncoImmunology · 2019 · 39 citations · Full text

, , +17

Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals

Heng Zhou, Laura Mondragón, Wei Xie et al. · Cell Death and Disease · 2018 · 23 citations · Full text

The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma

Brynjar Mauseth, Ketil André Camilio, Jihua Shi et al. · Molecular Therapy — Oncolytics · 2019 · 20 citations · Full text

Rows per page

1–5 of 6